Clinical trial
Compassionate Use Study of Epi-ON Corneal Collagen Crosslinking Performed Using UVA Exposure on Eyes With Ectatic Corneal Diseases for Subjects With Down Syndrome
NCT07135167 is registered in ClinicalTrials.gov with Woolfson Eye Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Compassionate Use Study of Epi-ON Corneal Collagen Crosslinking Performed Using UVA Exposure on Eyes With Ectatic Corneal Diseases for Subjects With Down Syndrome
- Lead sponsor
- Woolfson Eye Institute
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- August 1, 2025
- Completion date
- December 31, 2028
- Enrollment
- 225 (estimated)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.
down syndrome (ds), forme fruste keratoconus (ffk), keratoconus, pellucid marginal degeneration